YourChoice Therapeutics

YourChoice therapeutics is revolutionizing the contraceptive market…

Berkeley, United States · $15.2M raised

Employees
1–10
Total Funding
$15.2M
Last Round
$15.0M Series AJul 2022
Rounds
2

About

YourChoice Therapeutics is revolutionizing the global contraceptive market. Our vision is to develop non-hormonal contraceptives to provide both women and men with birth control options that lack the associated risks of hormone-based options but are equally effective. Traditionally, it has been the women’s financial and health burden to have a contraceptive in place. Our first goal is therefore to bring a novel non-hormonal, on-demand and low cost female contraceptive to the market that will substantially improve their quality of life and well-being. Our second goal is to develop the first ever non-surgical and highly effective non-hormonal contraceptive for men. Currently, male contraception is limited to two main options – vasectomy or condoms. Having such options available to both women and men will globally allow for much better family planning, reduce the number of unwanted pregnancies including abortions and therefore reduce costs and ensure contraceptive health and well-being.

Summary

YourChoice Therapeutics is a Biotech company based in Berkeley, United States. It has raised $15.2M in total across 2 rounds, most recently a $15.0M Series A round in Jul 2022. Investors include Future Ventures, Y Combinator Continuity Fund and 305 Ventures.

Tech & App Stack

1 technologies & apps tracked

Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Series ASeries AJul 2022
$15.0M

Sign up to see all 2 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies